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ABSTRACT
The gastrointestinal system is commonly implicated in Systemic Lupus Erythematosus (SLE). Ascites, produced by several mechanisms has 
been reported as a systemic manifestation of lupus, but only rarely as an initial presentation of the disease. Its appearance is often insidious 
and without abdominal pain. Chylous ascites (such as chyle in the peritoneal cavity) has seldom been reported in SLE. We describe a case of 
chylous ascites in an SLE patient, reviewing the other published cases, its pathophysiology and its management.
LEARNING POINTS
•  Chylous Ascites in Systemic Lupus Erythematous (SLE) patients is a rare finding that needs an organized approach to exclude other 
common etiologies. 
• Lymphatic obstruction as a result of inflammation may be a plausible explanation of Chylous Ascites formation in SLE patients.
• Chylous Ascites seems to respond well to steroids and have a low relapse incidence.
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INTRODUCTION
Systemic lupus erythematosus (SLE) is a multisystemic chronic autoimmune disease. Gastrointestinal system involvement in SLE is commonly 
reported as vasculitis, malabsorption and protein-losing enteropathy[1]. However, any type of presentation may develop at any time of the 
systemic disease, making its clinical course unpredictable. 
Ascites is a systemic manifestation of lupus which includes several mechanisms[1]: hypoalbuminemia produced by nephrotic syndrome in 
cases of lupus nephritis or protein-losing enteropathy;  right heart failure complicating lupus pericarditis;  portal hypertension caused by 
vascular thrombosis in the antiphospholipid syndrome (i.e., thrombosis of the portal veinor Budd-Chiari syndrome). Ascites may also result 
from inflammatory serositis from the same mechanism as that of pericarditis and pleuritis, with an exudative effusion that is positive for 
both antinuclear  and anti-DNA antibodies. Its appearance is often insidious and painless.
There have been few reports of chylous ascites (i.e. chyle in the peritoneal cavity). The composition of chylous ascites is identical to that of 
the thoracic duct with a triglyceride 2-8 times higher than plasma and usually greater than 110mg/dL[2]. We describe a rare case of chylous 
ascites in a SLE patient.
CASE REPORT
A 30-year-old female Caucasian presented with abdominal distension, asthenia and pelvic pain. Initial physical exam and laboratory results 
were unremarkable. She gave 13-year history of SLE diagnosed on the basis of laboratory results (Table 1). Although persistently ANA 
positive, she had been in remission for 13 years. She had initially presented with pleurisy, photosensitivity and fever that were all well 
controlled with prednisolone 10 mg/daily, hydroxychloroquine 300mg/daily, and also a methotrexate 15mg/weekly dose up until 1 year ago, 
when it that had been stopped because of hepatotoxity. 
On abdominal ultrasound, only a minor peri-caecal lamina of peritoneal liquid was found. On magnetic resonance, there was mild ascites, 
diffuse parietal and visceral pelvic peritoneal thickening and an inflamed bladder wall. A diagnosis of interstitial cystitis was made and her 
steroid dose was increased to 20mg/daily and she was advised to hydrate. 
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She was followed-up for 1 year with serial abdominal ultrasounds, which showed bilateral inguinal lymphadenopathy with inflammatory 
characteristics and progressively increasing ascites.
Parameters At SLE diagnosis At CA diagnosis Evolution Reference Value
Blood
Leucocytes 1750 1550 790 4400-11000 cells/μL
Hemoglobin 9.8 10.7 8.4 12.3-15.7 g/dL
Neutrophils 1100 320 1890 1800-7800 cells/μL
Lymphocytes 870 310 980 1100-4800 cells/μL
Thrombocytopenia 16,0000 10,0000 68,000 15,0000-45,0000 plt/mm3
Erythrocyte sedimentation rate 32 34 32 <38 mm/h
C-reactive protein 16 24 17 <6 mg/dL
Total protein 6.5 7.4 6.9 6.0-8.0 g/dL
IgG/IgA - 12.4/1.25 - 7-16 and 0.7-4.0 g/dL
Albumin 3.2 3.3 2.9 3.8-4.4 g/dL
TGP 15 22 12 10-36 U/dL
TGO 19 22 18 10-30 U/dL
GTT 20 22 18 32-104 U/L
FA 48 62 57 32-104 U/L
Creatinine 0.9 0.96 0.85 0.5-0,9 mg/dL
Urea 45 59 30 10-50 mg d/L
C3 0.62 0.7 0.84 0.9-1.80 g/L
C4 0.04 0.12 0.21 0.09-0.36 g/L
Antinuclear antibodies Positive Positive Positive -
Anti-dsDNA 125 98 56 <15 U/ImL
Lupus coagulant Negative Negative Negative -
Anticardiolipin - - Negative -
b2-Glicoproteina - - Negative -
Total cholesterol - 174 - <190 mg/dL
Triglycerides - 98 - <140 g/dL
Hemoculture - Sterile - -
Ser Hepatitis B - Negative - -
Ser Hepatitis C -- Negative - -
Ser CMW - Negative - -
Ser Leishmania - Negative - -
Plasmodium - Negative - -
HIV - Negative - -
Quantiferon - Negative - -
Urine Urine analysis Normal Normal Normal -
P e r i t o n e a l 
liquid
Triglycerides - 289 - 110 mg/dL
Leucocyte - 250 - Cells/uL
Neutrophils - 40% neutrophils - -
Glucose - 98 - mg/dL
Albumin - 3.12 - g/dL
Serum - ascites gradient - 1.2 - -
Adenosine desaminase - 22 - <40 U/L
Cytological exam - no lupus
no malignant cells
- -
Gram stain - Absent - -
Stain acid fast bacilli - Absent - -
Microbio culture - Sterile - -
ANA - Positive - -
Anti- SSA - Positive - -
Table 1: Laboratory results of blood, urine and peritoneal liquid tests
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Review of her laboratory data (Table 1) suggested that she might have a lymphoproliferative disease. The patient was submitted to a positron 
emission tomography that showed an increase in her inguinal lymph nodes and a diffuse moderate ascites along the mesentery, pelvis 
and perihepatic and perisplenic spaces. Paracentesis was performed, retrieving a milky-appearing turbid liquid that was alkaline, rich in 
triglycerides (Fig. 1) and contained chylomicrons on electrophoresis but no cytological abnormalities.
 An ascites liquid flow cytometry showed a reduced B-lymphocytes percentage (%) and a normal CD4/CD8 ratio. Immunoblotting analysis 
of peritoneal effusion was positive for antinuclear antibodies. Follow-up laboratory results showed hypergammaglobulinemia without 
monoclonal component. A bone biopsy showed normal shaped bone trabeculae; 30% cellularity; and a myeloid:erythroid ratio 1:1 . Serum 
tumor markers were all negative, except a mildly elevated CA125 of 92 kU/L (normal range <35kU/L). Once the common causes of chylous 
ascites had been excluded she was treated with cyclosporine up to a maximum of 250mg/day for 1 year, granulocyte-stimulating factors 
and repeated paracentesis, and maintenance prednisolone 20mg/daily. During the next 4 years, she continued prednisolone 5mg/daily and 
cyclosporine 150mg/daily and she underwent monthly paracentesis. Her hematologic changes improved and her clinical condition remained 
stable.  
DISCUSSION
Chylous ascites is a rare form of ascites most often seen in women, especially those of child-bearing age, and usually in those of non-European 
descent[1,4]. It has previously been reported in SLE as a presenting manifestation of the disease. This the first report of it as a finding late in 
the course of the disease. A possible mechanism for chylous acites may be lymphadenopathy, which is usually a benign finding in SLE that 
is commonly seen in young patients with cutaneous involvement and constitutional symptoms[3,5]. In our patient, for logistical reasons, we 
did not perform a lymphoscintigraphy. However, computerized tomography (CT), magnetic resonance imaging (MRI) and positron emission 
tomography (PET) scans did not show an abnormal lymphatic drainage in the form of enhanced lymph flow or lymphatic obstruction[3]. 
Another hypothesis is the association between enteropathy and chylous ascites. However, the diagnosis of lupus-associated protein-losing 
enteropathy relies on characteristic clinical and laboratory features of SLE and on the exclusion of other causes[3]. In about two thirds of 
the reported cases [5], it was also the first manifestation of SLE. Immunologic compromise is common, as seen in our patient, and results in 
lymphocytopenia, hypogammaglobulinemia and increased susceptibility to infection[2]. In our case, protein-losing enteropathy was initially 
excluded given the absence of typical criteria.
Acute lupus peritonitis was also a consideration, however patients with this complication typically develop acute massive ascites, complain 
of severe abdominal pain and have evidence of bowel wall thickening on imaging. Chronic lupus peritonitis is a plausible diagnosis. Lymphatic 
obstruction due to plasmacytic deposits may also be an explanation[4]. 
The standard treatment for chylous ascites is not yet established. Although most chylous effusions respond to an initial approach with a 
high-protein and low-fat diet with medium-chain triglycerides, in SLE chylous ascites immunosuppression with high-dose steroids, followed 
by steroid-sparing therapy has been the most common approach. 
Other approaches include frequent paracentesis, surgery (using sclerosing agents and suture ligation of the thoracic duct) or peritoneovenous 
shunting. Most cases have good outcome, with a relapse rate described in 20–30% of those associated with protein-losing enteropathy[2].
Finally, malignancy may also be a cause since 5 out of the 6 cases reported had positive anti-SSA antibody, which is known to be associated 
with increased risk of developing non-Hodgkin lymphoma[5].
CONCLUSIONS
Chylous ascites is a rare diagnosis, even rarer in an autoimmune disease condition. Its causal mechanisms are several and their identification 
may contribute to a better management.
Figure 1: Syringes with chyle peritoneal fluid
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